KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $693.3 million.

  • Edwards Lifesciences' Receivables - Net fell 317.04% to $693.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $693.3 million, marking a year-over-year decrease of 317.04%. This contributed to the annual value of $609.1 million for FY2024, which is 2104.99% down from last year.
  • Per Edwards Lifesciences' latest filing, its Receivables - Net stood at $693.3 million for Q3 2025, which was down 317.04% from $697.0 million recorded in Q2 2025.
  • Edwards Lifesciences' Receivables - Net's 5-year high stood at $817.6 million during Q1 2024, with a 5-year trough of $582.2 million in Q4 2021.
  • Over the past 5 years, Edwards Lifesciences' median Receivables - Net value was $669.2 million (recorded in 2025), while the average stood at $679.3 million.
  • In the last 5 years, Edwards Lifesciences' Receivables - Net skyrocketed by 1998.44% in 2023 and then plummeted by 2104.99% in 2024.
  • Over the past 5 years, Edwards Lifesciences' Receivables - Net (Quarter) stood at $582.2 million in 2021, then rose by 10.44% to $643.0 million in 2022, then grew by 19.98% to $771.5 million in 2023, then dropped by 21.05% to $609.1 million in 2024, then grew by 13.82% to $693.3 million in 2025.
  • Its Receivables - Net stands at $693.3 million for Q3 2025, versus $697.0 million for Q2 2025 and $669.2 million for Q1 2025.